India's drug regulator tightens surveillance against unauthorized weight-loss drug sales
India's drug regulator tightens surveillance against unauthorized weight-loss drug sales
ReutersTue, March 24, 2026 at 5:25 AM UTC
0
FILE PHOTO: Boxes of Ozempic and Mounjaro, semaglutide and tirzepatide injection drugs used for treating type 2 diabetes and made by Novo Nordisk and Lilly, is seen at a Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo
March 24 (Reuters) - India's drug regulator tightened surveillance against unauthorized sale and promotion of weight-loss drugs, the country's health ministry said on Tuesday, following local drugmakers launching a wave of generic, cheaper versions of Novo Nordisk's blockbuster drugs Ozempic and Wegovy.
Advertisement
The regulator conducted inspections at 49 entities, including drug wholesalers, retailers, and slimming clinics, in recent weeks as it clamps down on the unauthorized sale and use of weight-loss drugs, according to the statement.
(Reporting by Rishika Sadam in Hyderabad and Urvi Dugar in Bengaluru; Editing by Rashmi Aich)
Source: “AOL Breaking”
